Transferred Photothermal to Photodynamic Therapy Based on the Marriage of Ultrathin Titanium Carbide and Up-Conversion Nanoparticles
In this research, upconversion nanoparticles (UCNPs) are used as a light conversion carrier, and their deep light source penetrability is closely combined with ultrathin two-dimensional (2D) Ti3C2Tx to explore the application efficiency of the complex in phototherapy. Due to the advantages of 2D Ti3...
| Veröffentlicht in: | Langmuir : the ACS journal of surfaces and colloids. - 1992. - 36(2020), 43 vom: 03. Nov., Seite 13060-13069 |
|---|---|
| 1. Verfasser: | |
| Weitere Verfasser: | , , , , , |
| Format: | Online-Aufsatz |
| Sprache: | English |
| Veröffentlicht: |
2020
|
| Zugriff auf das übergeordnete Werk: | Langmuir : the ACS journal of surfaces and colloids |
| Schlagworte: | Journal Article Research Support, Non-U.S. Gov't titanium carbide 12070-08-5 Titanium D1JT611TNE |
| Zusammenfassung: | In this research, upconversion nanoparticles (UCNPs) are used as a light conversion carrier, and their deep light source penetrability is closely combined with ultrathin two-dimensional (2D) Ti3C2Tx to explore the application efficiency of the complex in phototherapy. Due to the advantages of 2D Ti3C2Tx with its high absorbance to ultraviolet/visible light, rich atomic defects to load the drugs, and adjustable thinner structure, this 2D material is beneficially applied as the energy donor. UCNPs@Ti3C2Tx with a photothermal conversion efficiency of 20.7% is proven with the ability to generate reactive oxygen species under a 980 nm laser at the cellular level. Importantly, the main photothermal therapy method can be changed to a photodynamic therapy method due to the degradation of Ti3C2Tx to TiO2 under the oxygen-bearing environment. The in vivo experiment was continued to verify that UCNPs@Ti3C2Tx can kill tumor cells and inhibit tumor growth within a certain period. In addition, in vivo treatment with a combination of immunotherapy and phototherapy of UCNPsTi3C2Tx is carried out to achieve stronger tumor inhibition over the prolonged time points |
|---|---|
| Beschreibung: | Date Completed 21.06.2021 Date Revised 21.06.2021 published: Print-Electronic Citation Status MEDLINE |
| ISSN: | 1520-5827 |
| DOI: | 10.1021/acs.langmuir.0c02521 |